← Eichor
Study identifier: NCT06809868 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Role of Transposable Elements in Septic Immune Aging

Condition: Sepsis · Sepsis and Septic Shock · Sepsis With Multiple Organ Dysfunction (MOD)  ·  Sponsor: University of California, San Francisco

PhaseN/A
Planned participants116
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The goal of this observational study is to learn about how transposable element levels affect the patient outcomes in sepsis. The main questions it aims to answer is: 1. Do transposable elements prematurely age the immune systems of patients with sepsis? 2. Do transposable elements correlate with increased mortality in patients with sepsis in the ICU? 3. Do transposable elements correlate with increased amount of secondary infections in patients with sepsis in the ICU? Participants will have blood drawn from them but will not be subjected to additional interventions.

This description comes directly from the study's public registry record.

Talk to the study team

Alexendar R Perez, M.D., Ph.D  ·  415-476-1000  ·  Alexendar.Perez@ucsf.edu

Matthieu Legrand, M.D., Ph.D  ·  415-476-1000  ·  matthieu.legrand@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of California, San FranciscoSan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06809868